Propranolol, sometimes referred to as “Inderal” (brand name), is a non-cardioselective sympatholytic beta blocker that was first synthesized by British scientist James Black in 1964. As a non-selective beta blocker, propranolol prevents endogenous catecholamines (e.g. norepinephrine and epinephrine) from activating Beta-1 and Beta-2 adrenergic receptors within the CNS (central nervous system) and PNS (peripheral nervous …
Propranolol is a beta blocker originally synthesized in the 1960s by James W. Black, a British scientist. It is a derivative of older beta-adrenergic antagonists dichloroisoprenaline and pronethalol, each of which lacked safety and efficacy to warrant medicinal usage. Chemically, propranolol is formed upon insertion of an oxymethylene group into the aryl ethanolamine structure of …
Beta blockers are drugs that act on “beta receptors” within tissues of the sympathetic nervous system to inhibit stimulatory hormones such as epinephrine and norepinephrine. Medically they are utilized primarily to help manage cardiac arrhythmias, prevent heart attacks, and reduce blood pressure. The first effective beta blockers were documented in the early 1960s as a …